A nurse is evaluating the effectiveness of mucolytics prescribed to a client with upper respiratory symptoms. Which assessment finding indicates positive outcomes?

A. The client experiences drowsiness following mucolytic administration: Drowsiness is not a therapeutic goal of mucolytic therapy and may indicate a side effect or a different pharmacological interaction. Mucolytics like acetylcysteine are designed to alter the physical properties of mucus rather than induce sedation. This finding would be an adverse or unrelated outcome. B. The client requires supplemental oxygen to maintain oxygen saturation: The need for supplemental oxygen suggests that gas exchange is severely compromised, possibly by worsening pulmonary congestion or inflammation. If a mucolytic were effective, airway patency should improve, potentially reducing the need for exogenous oxygen. This finding indicates clinical deterioration rather than success. C. The client complains of persistent dry cough with scant mucus production: Mucolytics are intended to thin thick, tenacious secretions to make them easier to expectorate. A persistent dry cough suggests that secretions are either absent or remain too viscous to be moved. This outcome indicates the therapy has not achieved the desired liquefaction of mucus. D. The client reports easier clearance of mucus and improved breathing: The primary mechanism of mucolytics is the cleavage of disulfide bonds in mucoproteins to reduce sputum viscosity. Successful treatment is evidenced by the patient's ability to mobilize and expel secretions with less effort. This directly leads to improved airway diameter and more efficient ventilation.